Advertisement

Topics

Santen Incorporated Company Profile

17:18 EST 24th November 2017 | BioPortfolio

Santen Inc. is responsible for the development and commercialization of eye care pharmaceuticals in the U.S. It also serves as the international headquarters for Santen's business in Europe, with responsibility for research and development, international regulatory affairs, manufacturing, sales, marketing, and distribution.

Location

555 Gateway Drive
Napa
CA
94558
United States of America

Contact

Phone: 707 254 1750
Fax: 707 254 1769
Email: info@santeninc.com


News Articles [17 Associated News Articles listed on BioPortfolio]

Santen initiates phase 2a study of DE-122 for wet AMD

Santen has initiated a phase 2a clinical study of the efficacy and safety of intravitreal injections of DE-122 for the treatment of wet age-related macular degeneration, according to a joint press rel...

Santen Pharmaceutical Co., Ltd. Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 14062017] Prices from USD $350

Santen Pharmaceutical Co., Ltd. Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's Santen Pharmaceutical Co., Ltd. Mergers Acquisitions MA, Partnerships Alli...

Santen starts Phase IIa of wet AMD candidate DE-122

CHMP recommends Santen's Verkazia for keratoconjunctivitis

Santen Pharmaceutical Co., Ltd. ADR 2017 Q2 - Results - Earnings Call Slides

Vical Incorporated Announces Pricing of $25 Million Underwritten Public Offering of Common Stock

SAN DIEGO, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced the pricing of its underwritten public offering of 14,285,714 shares of common stock or common stock ...

Santen Pharmaceutical Co Ltd 4536 Financial and Strategic SWOT Analysis Review [Report Updated: 17082017] Prices from USD $125

Santen Pharmaceutical Co Ltd 4536 Financial and Strategic SWOT Analysis Review provides you an indepth strategic SWOT analysis of the company's businesses and operations. The profile has been compile...

Santen Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 23082017] Prices from USD $250

SummarySanten Inc Santen, a subsidiary of Santen Pharmaceutical Co Ltd is a developer, manufacturer and distributor of ophthalmic pharmaceutical products. The company offers products in therapeutic ar...

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [43 Associated Companies listed on BioPortfolio]

Santen Phamaceutical Co., Ltd.

Since its foundation in 1890, Santen Pharmaceutical Co., Ltd. has contributed to the protection and improvement of people's eyesight and health. Santen's integrated operations extend from research and...

Santen GmbH.

As a specialty company dedicated to the ophthalmic and anti-rheumatic fields, Santen carries out the research, development, sales, and marketing of pharmaceuticals. The company ha...

Santen Inc.

Santen Inc., based in Emeryville, California, is the U.S. subsidiary of Santen Pharmaceutical Co., Ltd., a billion-dollar global company headquartered in Osaka, Japan since 1890. ...

Santen Incorporated

Santen Inc. is responsible for the development and commercialization of eye care pharmaceuticals in the U.S. It also serves as the international headquarters for Santen's business in Europe, with resp...

Santen Pharmaceutical Co., Ltd.

More Information about "Santen Incorporated" on BioPortfolio

We have published hundreds of Santen Incorporated news stories on BioPortfolio along with dozens of Santen Incorporated Clinical Trials and PubMed Articles about Santen Incorporated for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Santen Incorporated Companies in our database. You can also find out about relevant Santen Incorporated Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...


Corporate Database Quicklinks



Searches Linking to this Company Record